<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
(Rule 13d-102)
Information statement pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
ALLIED HEALTHCARE PRODUCTS, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
- --------------------------------------------------------------------------------
(Title of Class of Securities)
019222 10 8
- --------------------------------------------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6
<PAGE>
SCHEDULE 13G
<TABLE>
<CAPTION>
CUSIP No. 019222 10 8 Page 2 of 6 Pages
- --------------------------------------------------------------------------------
<S> <C> <C>
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
THE WASHINGTON UNIVERSITY 43-0653611
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
MISSOURI
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
601,500
SHARES
-------------------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
-0-
OWNED BY
-------------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
601,500
REPORTING
-------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
PERSON
-0-
WITH
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
601,500
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES [_]
CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.7%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
EP
- --------------------------------------------------------------------------------
</TABLE>
<PAGE>
Schedule 13G
Item 1.
(a) Name of Issuer:
ALLIED HEALTHCARE PRODUCTS, INC.
(b) Address of Issuer's Principal Executive Offices:
1720 Sublette Avenue
St. Louis, Missouri 63110
Item 2.
(a) Name of Person Filing:
THE WASHINGTON UNIVERSITY
(b) Address of Principal Business Officer or, if none, Residence:
Campus Box 1058
One Brookings Drive
St. Louis, Missouri 63130
(c) Citizenship:
Missouri
(d) Title of Class of Securities:
Common Stock
(e) CUSIP Number:
019222 10 8
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b),
check whether the person filing is:
f [x] Endowment Fund
<PAGE>
Item 4. Ownership.
(a) Amount Beneficially Owned:
601,500
(b) Percent of Class: 7.7%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
601,500
(ii) shared power to vote or to direct the vote:
-0-
(iii) sole power to dispose or to direct the disposition of:
601,500
(iv) shared power to dispose or to direct the disposition of:
-0-
Item 5. Ownership of Five Percent or Less of a Class.
n/a
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
n/a
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company.
n/a
Item 8. Identification and Classification of Members of the Group.
n/a
Item 9. Notice of Dissolution of the Group.
n/a
<PAGE>
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired for the purpose of and do not
have the effect of changing or influencing control of the issuer of
such securities and were not acquired in connection with or as a
participant in any transaction having such purposes or effect.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: January ____, 1999
THE WASHINGTON UNIVERSITY
By:____________________________________
Name: Barbara A. Feiner
Title: Chief Financial Officer
